ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Overview Fund Activity
Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

25 hedge funds and large institutions have $35.3M invested in Oncternal Therapeutics, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
+5
Holders Change %
+25%
% of All Funds
0.57%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
6
Increased
4
Reduced
6
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.67M
2
Millennium Management
Millennium Management
New York
+$749K
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$634K
4
EI
EAM Investors
California
+$551K
5
Barclays
Barclays
United Kingdom
+$100K

Top Sellers

1
FHA
First Horizon Advisors
Tennessee
-$82.2K
2
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$37.7K
3
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$18K
4
IA
IFP Advisors
Florida
-$18K
5
BI
BVF Inc
California
-$12.5K
Name Holding Trade Value Shares
Change 		Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
$1K – – –
1
2